Matthew Biegler | BiotechTV

top of page

Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference

Matt Biegler summarizes a breast cancer panel from the conference and talks about recent data from Relay and upcoming data from Gilead....

Bright Minds

Sep 26, 2024

Houston Oncology Summit: Oppenheimer analyst Matthew Biegler talks about synthetic lethality

He describes how PARP inhibitors were initial successes and where the field is going now beyond PARP with new targets.

Bright Minds

Sep 21, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page

Houston Oncology Summit: Oppenheimer analyst Matt Biegler discusses the breast cancer space and learnings from the conference

Houston Oncology Summit: Oppenheimer analyst Matthew Biegler talks about synthetic lethality

Follow BiotechTV

Sponsors

Sponsor Spotlight